Document is current
Any future updates will be listed below
-
Authors
Li, Na
Li, Rui
Zheng, Hong-Yi
He, Wen-Qiang
Duan, Ru-Fei
Li, Xia
Tian, Ren-Rong
Li, Hui-Qin
Dong, Xing-Qi
Shen, Zhi-Qiang
Zheng, Yong-Tang
-
Funding
Funding for this research was provided by:
the Key Laboratory of Bioactive Peptides of Yunnan Province (HXDT-2022-3)
the National Key R & D Program of China (2023YFC2306700)
the Yunnan Key R & D Program (202403AC100011)
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 18 February 2025
First Online: 24 February 2025
Declarations
:
: This study was approved by the Ethics Committee of Yunnan Infectious Disease Hospital (approval No. Ke2024005), and informed consent from the participants was waived due to the use of anonymous data. The study was conducted in accordance with the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.
